Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Anticorps monoclonaux »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anticorps de l'hépatite B < Anticorps monoclonaux < Anticorps monoclonaux d'origine murine  Facettes :

List of bibliographic references indexed by Anticorps monoclonaux

Number of relevant bibliographic references: 512.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
001282 (2018) Ernest H S. Choy [Royaume-Uni] ; Leonard H. Calabrese [États-Unis]Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.
001315 (2018) Frits Van Rhee [États-Unis] ; Peter Voorhees [États-Unis] ; Angela Dispenzieri [États-Unis] ; Alexander Foss [Norvège] ; Gordan Srkalovic [États-Unis] ; Makoto Ide [Japon] ; Nikhil Munshi [États-Unis] ; Stephen Schey [Royaume-Uni] ; Matthew Streetly [Royaume-Uni] ; Sheila K. Pierson [États-Unis] ; Helen L. Partridge [États-Unis] ; Sudipto Mukherjee [États-Unis] ; Dustin Shilling [États-Unis] ; Katie Stone [États-Unis] ; Amy Greenway [États-Unis] ; Jason Ruth [États-Unis] ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan [États-Unis] ; Raj Jayanthan [États-Unis] ; Elaine S. Jaffe [États-Unis] ; Heather Leitch [Canada] ; Naveen Pemmaraju [États-Unis] ; Amy Chadburn [États-Unis] ; Megan S. Lim ; Kojo S. Elenitoba-Johnson ; Vera Krymskaya [États-Unis] ; Aaron Goodman [États-Unis] ; Christian Hoffmann [Allemagne] ; Pier Luigi Zinzani [Italie] ; Simone Ferrero [Italie] ; Louis Terriou [France] ; Yasuharu Sato [Japon] ; David Simpson [Nouvelle-Zélande] ; Raymond Wong [Hong Kong] ; Jean-Francois Rossi [France] ; Sunita Nasta [États-Unis] ; Kazuyuki Yoshizaki [Japon] ; Razelle Kurzrock [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Corey Casper [États-Unis] ; Eric Oksenhendler [France] ; David C. Fajgenbaum [États-Unis]International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
001323 (2018) Abdul Rafeh Naqash [États-Unis] ; Li V. Yang [États-Unis] ; Edward J. Sanderlin [États-Unis] ; Druid C. Atwell [États-Unis] ; Paul R. Walker [États-Unis]Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report.
001348 (2018) Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie]Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.
001379 (2018) Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Wararu Yamamoto [Japon] ; Takanori Fujimura [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Ohnishi [Japon] ; Kengo Akashi [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Toru Hirano [Japon] ; Kosuke Ebina [Japon] ; Ryuji Uozumi [Japon] ; Hiromu Ito [Japon] ; Masao Tanaka [Japon] ; Koichiro Ohmura [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon]Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.
001382 (2018) Expanded table: some biologic agents and JAK inhibitors for RA.
001399 (2018) Yukimi Otsuka [Japon] ; Chikako Kiyohara [Japon] ; Yusuke Kashiwado [Japon] ; Takuya Sawabe [Japon] ; Shuji Nagano [Japon] ; Yasutaka Kimoto [Japon] ; Masahiro Ayano [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Yojiro Arinobu [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon] ; Takahiko Horiuchi [Japon]Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
001410 (2018) K L Winthrop [États-Unis] ; X. Mariette [France] ; J T Silva [Espagne] ; E. Benamu [États-Unis] ; L H Calabrese [États-Unis] ; A. Dumusc [Suisse] ; J S Smolen [Autriche] ; J M Aguado [Espagne] ; M. Fernández-Ruiz [Espagne]ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
001412 (2018) Drugs for rheumatoid arthritis.
001423 (2018) Shingo Nakayamada [Japon] ; Satoshi Kubo [Japon] ; Maiko Yoshikawa [Japon] ; Yusuke Miyazaki [Japon] ; Naoki Yunoue [Japon] ; Shigeru Iwata [Japon] ; Ippei Miyagawa [Japon] ; Shintaro Hirata [Japon] ; Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
001429 (2018) Lucía Jiménez-Pichardo [Espagne] ; Rocío Gázquez-Pérez [Espagne] ; Jesús Francisco Sierra-Sánchez [Espagne]Degree of prescriber's knowledge about variability in biological drugs "innovators" in manufacturing process.
001446 (2018) Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
001460 (2018) Karien Bloem [Pays-Bas] ; Tiny Schaap [Pays-Bas] ; Ronald Boshuizen [Pays-Bas] ; Eva L. Kneepkens [Pays-Bas] ; Gerrit J. Wolbink [Pays-Bas] ; Annick De Vries [Pays-Bas] ; Theo Rispens [Pays-Bas]Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra® microsampler vs dried blood spot.
001483 (2018) Pauline Baudart [France] ; Johann Cesini [France] ; Christian Marcelli [France]Atypical juxta-articular form of Dercum's disease in a patient treated with tocilizumab for rheumatoid arthritis.
001515 (2018) Fereshteh Nazari [États-Unis] ; Alexander T. Pearson [États-Unis] ; Jacques Eduardo Nör [États-Unis] ; Trachette L. Jackson [États-Unis]A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.
001545 (2017) Yanyi Li [République populaire de Chine] ; Weiting Zhang [République populaire de Chine][IL-6: the next key target for rheumatoid arthritis after TNF-α].
001546 (2017) François Spertini [Suisse][Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab].
001552 (2017) Margarita Candil [Suisse] ; Pascal Zufferey [Suisse][Anti-IL-6 : new therapeutic trends].
001559 (2017) Melissa Y. Yeung [États-Unis] ; Steven Gabardi [États-Unis] ; Mohamed H. Sayegh [États-Unis]Use of polyclonal/monoclonal antibody therapies in transplantation.
001581 (2017) Dae Hyun Yoo [Corée du Sud]Treatment of adult-onset still's disease: up to date.
001583 (2017) Benjamin Chastek [États-Unis] ; Chieh-I Chen [États-Unis] ; Clare Proudfoot [Royaume-Uni] ; Shraddha Shinde [États-Unis] ; Andreas Kuznik [États-Unis] ; Wenhui Wei [États-Unis]Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Anticorps monoclonaux" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Anticorps monoclonaux" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Anticorps monoclonaux
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021